Inscobee, 10% Owner of Apimeds Pharmaceuticals US APUS, has filed 1 purchase and 0 sales on the open market. The latest trade was on 25/05/12.

IN

IN

Inscobee

10% Owner

Company

Apimeds Pharmaceuticals US APUS

First filing

25/06/11

Trades

11 trades

Buys / sales

1 / 0

12-month net buying

No record

Last trade

25/05/12

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Apimeds Pharmaceuticals USAPUS	Open-market buy	25/05/12	25/05/14	500,000 sh	$4.00	$2,000,000	+33.7%